| Bid Price | 209.00p | High Price | 214.00p |
|---|
| Ask Price | 212.00p | Low Price | 208.00p |
|---|
| Open Price | 212.00p | Spread | 1.42% |
|---|
| Prev Close | 207.00p | Volume | 22,713 |
|---|
Hutchmed (China) Limited Historic Prices
| Date | Open | High | Low | Close | Volume |
|---|
| Apr 17, 2025 | 212.00 | 214.00 | 208.00 | 212.00 | 22,713 |
| Apr 16, 2025 | 211.00 | 216.00 | 207.00 | 207.00 | 17,049 |
| Apr 15, 2025 | 219.00 | 221.00 | 214.01 | 218.00 | 26,478 |
| Apr 14, 2025 | 215.00 | 228.00 | 213.00 | 225.00 | 97,115 |
Hutchmed (China) Limited Information
| Name | Hutchmed (China) Limited | Index | FTSE AIM 100 |
|---|
| ISIN | KYG4672N1198 | Epic | HCM |
|---|
| Type | Equity | Currency | GBX |
|---|
| Record Status | Active | Trading Segment | AMSM |
|---|
| Industry | Drug Manufacturers - Specialty & Generic | Sector | Healthcare |
|---|
| EMS | 1,000 | Trading Status | Closed |
|---|
| Shares in Issue | 854.88 m | Prev Close | 207.00p |
|---|
| PE Ratio | 70.129568 | Market Cap | £1.81 bn |
|---|
| Div Yield | 0 | Div per Share | $NaN |
|---|
| EPS | $0.01 | Div Cover | NaN |
|---|
| PEG | n/a | EPS Growth (%) | 0.00 |
|---|
| ROCE | 0.014269 | DPS Growth (%) | 0 |
|---|
| Current Ratio | 2.832349 | Quick Ratio | 2.665837 |
|---|
Hutchmed (China) Limited Director Deals
| Declared | Type | Director | Pos. | Volume / Price | Value |
|---|
| 14/03/25 | TIN | Weiguo Su | D | 19,913 @ £0.00 | £0.00 |
| 21/10/24 | TIN | Graeme Jack | D | 9,690 @ $0.00 | $0.00 |
| 21/10/24 | TIN | Dan Eldar | NED | 9,690 @ $0.00 | $0.00 |
| 21/10/24 | TIN | Paul Carter | D | 8,235 @ $0.00 | $0.00 |
| 21/10/24 | TIN | Shu Kam Tony Mok | NED | 9,690 @ $0.00 | $0.00 |
| 05/03/24 | TIN | Johnny Fung | FD | 227,115 @ £0.00 | £0.00 |
| 05/03/24 | TIN | Weiguo Su | D | 1,403,175 @ £0.00 | £0.00 |
| 24/10/23 | TIN | Graeme Jack | D | 29,070 @ $0.00 | $0.00 |
| 24/10/23 | TIN | Dan Eldar | NED | 29,070 @ $0.00 | $0.00 |
| 24/10/23 | TIN | Paul Carter | D | 24,705 @ $0.00 | $0.00 |
Hutchmed (China) Limited News
